EU secures 400 million doses of Janssen’s COVID-19 Vaccine Candidate

  Johnson & Johnson on 8 Oct 2020 announced that the European Commission (EC), acting on behalf of the Europea...

October 9, 2020 | Friday | News
CEPI establishes global centralized COVID-19 vaccine candidates assessment network

The Coalition for Epidemic Preparedness Innovations (CEPI) in Norway has announced partnerships with five clinical sampl...

October 8, 2020 | Thursday | News
Australia invests $2.3 B on native COVID-19 vaccine

The Australian Government is investing a total of $2.3 billion to support home-grown researchers and manufacturers to de...

October 8, 2020 | Thursday | News
RDIF, Trinity Pharma to supply 25M doses of Sputnik V to Nepal

The Russian Direct Investment Fund (RDIF), Russia’s sovereign wealth fund, and one of the leading pharmaceutical d...

September 29, 2020 | Tuesday | News
COVAXX initiates Ph 1 trial of COVID-19 vaccine in Taiwan

COVAXX, a subsidiary of United Biomedical Inc (UBI) headquartered in the US, has announced the first healthy a...

September 29, 2020 | Tuesday | News
J&J initiates global Ph 3 trial of COVID-19 vaccine candidate

Johnson & Johnson has announced the launch of its large-scale, pivotal, multi-country Phase 3 trial (ENSEMBLE) for i...

September 24, 2020 | Thursday | News
Australia now eligible to purchase COVID-19 vaccine doses through COVAX

The Australian Government has joined the COVAX facility, enabling the purchase of COVID-19 vaccine doses as they become ...

September 23, 2020 | Wednesday | News
Singapore focuses on COVID-19 vaccine technology for elders

Researchers from Monash University in Australia and the National University of Singapore have adapted new cancer and pan...

September 22, 2020 | Tuesday | News
Australia invests $6M in new COVID-19 vaccine projects

Australia will invest almost $6 million in additional funding from the Medical Research Future Fund’s (MRFF) Coron...

September 21, 2020 | Monday | News
Novavax & Serum Institute of India to manufacture COVID-19 Vaccine

Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases,&n...

September 16, 2020 | Wednesday | News
Taiwan & US to develop coronavirus, influenza combo patch vaccine

Vaxess Technologies, an innovative biotechnology company in the US developing the MIMIX smart release patch, has formed ...

September 15, 2020 | Tuesday | News
Oxford vaccine AZD1222 resumes clinical trial

Oxford university and AstraZeneca are to resume the international clinical trial of their proposed coronavirus vaccine c...

September 14, 2020 | Monday | News
Inovio partners with Thermo Fisher to manufacture COVID-19 vaccine

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect peop...

September 10, 2020 | Thursday | News
Intravacc receives US NIAID contract to develop enterovirus D68 vaccine

Intravacc, a global leader in translational research and development of viral and bacterial vaccines in the Netherlands,...

September 8, 2020 | Tuesday | News
Australia inks $1.7B worth agreement for COVID-19 vaccine

A free COVID-19 vaccine will be available progressively throughout 2021 in Australia, if promising trials prove successf...

September 8, 2020 | Tuesday | News
Australia deals with AstraZeneca for AZD1222 COVID-19 investigational vaccine

AstraZeneca’s COVID-19 vaccine candidate, AZD1222, as a potential candidate for an emergency use authorization (EU...

September 7, 2020 | Monday | News
Korean CRO to conduct Ph III trial of Sinovac's Covid-19 vaccine candidate in Bangladesh

Korea's LSK Global PS, a leading CRO to run Sinovac Phase III COVID-19 vaccine trial in Bangladesh. The company would m...

September 4, 2020 | Friday | News
Beximco inks COVID-19 vaccine pact with Serum Institute of India

Beximco Pharmaceuticals Limited (BPL) in Bangladesh and the Serum Institute of India Pvt. Ltd (SII), have announced an a...

August 31, 2020 | Monday | News